nonane has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Ayad, O; Leclerc, O; Lochead, A; Saady, M; Slowinski, F; Vache, J | 1 |
| Beher, D; Best, JD; Castro, JL; Clarke, E; Harrison, T; Jones, AB; Lewis, SJ; Lindon, MJ; Neduvelil, JG; Peachey, JE; Shearman, MS; Smith, AL; Stevenson, GI | 1 |
2 other study(ies) available for nonane and Alzheimer Disease
| Article | Year |
|---|---|
Synthesis of bridgehead-substituted azabicyclo[2.2.1]heptane and -[3.3.1]nonane derivatives for the elaboration of α7 nicotinic ligands.
Topics: Alkanes; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Azabicyclo Compounds; Chemistry, Pharmaceutical; Chlorides; Halogenation; Heptanes; Humans; Ligands; Magnetic Resonance Spectroscopy; Nicotinic Agonists; Protons; Pyridines; Receptors, Nicotinic; Schizophrenia; Stereoisomerism | 2011 |
A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core.
Topics: Alkanes; Alzheimer Disease; Amides; Amines; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Endopeptidases; Heterocyclic Compounds; Mice; Protease Inhibitors; Structure-Activity Relationship | 2005 |